Published in Cardiovasc Diabetol on July 06, 2017
High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. J Am Coll Cardiol (2013) 1.69
Effect of Intensive Statin Therapy on Coronary High-Intensity Plaques Detected by Noncontrast T1-Weighted Imaging: The AQUAMARINE Pilot Study. J Am Coll Cardiol (2015) 1.48
Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J (2015) 0.97
The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial. PLoS Med (2016) 0.83
Expression of NLRP3 in subcutaneous adipose tissue is associated with coronary atherosclerosis. Atherosclerosis (2015) 0.81
Usefulness of Lipoprotein (a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction. Circ J (2011) 0.81
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial. Cardiovasc Diabetol (2016) 0.79
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study. Cardiovasc Diabetol (2016) 0.78
Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography. JACC Cardiovasc Imaging (2011) 0.78
Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation. J Cardiol (2016) 0.78
Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men. Cardiovasc Diabetol (2016) 0.77
Plasma brain natriuretic peptide levels are elevated in patients with cancer. PLoS One (2017) 0.76
Emerging roles of sodium-glucose cotransporter 2 inhibitors in cardiology. J Cardiol (2016) 0.76
Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study. Cardiovasc Diabetol (2016) 0.76
Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study. Cardiovasc Diabetol (2016) 0.76
PPAR-γ agonist attenuates inflammation in aortic aneurysm patients. Gen Thorac Cardiovasc Surg (2015) 0.76
A novel cardioprotective mechanism of exogenous nitric oxide: inhibition of Rho-associated kinase activity. Hypertens Res (2015) 0.76
Novel insights into renovascular hypertension and cardio-renal protection by iron restriction. Hypertens Res (2016) 0.75
Iron-restricted pair-feeding affects renal damage in rats with chronic kidney disease. PLoS One (2017) 0.75
Response: Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2015;39:342-7). Diabetes Metab J (2015) 0.75
Gender-linked impact of epicardial adipose tissue volume in patients who underwent coronary artery bypass graft surgery or non-coronary valve surgery. PLoS One (2017) 0.75
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial. Cardiovasc Diabetol (2017) 0.75
Temporary dietary iron restriction affects the process of thrombus resolution in a rat model of deep vein thrombosis. PLoS One (2015) 0.75
The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: a study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe. J Nutr Biochem (2016) 0.75
Altered expression of intestinal duodenal cytochrome b and divalent metal transporter 1 might be associated with cardio-renal anemia syndrome. Heart Vessels (2017) 0.75
Impact of low-density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy. Nephrology (Carlton) (2016) 0.75
Clinical Outcomes of Pedal Artery Angioplasty for Patients With Ischemic Wounds: Results From the Multicenter RENDEZVOUS Registry. JACC Cardiovasc Interv (2017) 0.75
Is optical frequency domain imaging a promising modality for diagnosis of erosion? Pathol Int (2015) 0.75
Coronary angioscopic findings eight months after sirolimus-eluting stent implantation: a comparison between ST-elevation myocardial infarction and stable angina pectoris. EuroIntervention (2010) 0.75
Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure. Int J Cardiol (2016) 0.75
Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice. Heart Vessels (2016) 0.75
Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale. Lipids Health Dis (2017) 0.75
Safety and efficacy of liraglutide treatment in Japanese type 2 diabetes patients after acute myocardial infarction: A non-randomized interventional pilot trial. J Cardiol (2016) 0.75
Fibrin glue patch for pacemaker lead perforation of the right ventricular free wall: A case report. HeartRhythm Case Rep (2015) 0.75
Amelioration of arterial pressure lability: an unmissable target for diabetes management. Hypertens Res (2017) 0.75
Correction to: Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats. Transl Stroke Res (2017) 0.75
Experience of dietary iron intake restriction in patients with essential hypertension. Int J Cardiol (2016) 0.75
N-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study. Sci Rep (2017) 0.75
Coronary angioscopic findings 9 months after everolimus-eluting stent implantation compared with sirolimus-eluting stents. J Cardiol (2012) 0.75
Progressive idiopathic nodular glomerulosclerosis mimicking diabetic nephropathy without abnormal glycemic metabolism. Nephrology (Carlton) (2016) 0.75